Clinical trial
Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate…
NCT00003832 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003832 |
|---|---|
| Title | Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer |
| Official title | Cell Kinetic Study of Bromodeoxyuridine (BrdU) in Prostate Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer |
| Intervention type | Drug, Other, Procedure |
| Interventions | bromodeoxyuridine, conventional surgery, laboratory biomarker analysis |
| Enrollment | 75 |
| Start date | Jul 1, 1999 |
| Primary completion | Jun 1, 2002 |
| First posted | Sep 30, 2003 |
| Last update posted | Jan 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: